Trial
NCT03245840
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Shire
Collaborators
Takeda Development Center Americas, Inc.
Condition
Eosinophilic Esophagitis (EoE)
Intervention
Budesonide oral suspension
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-19